Ursprung des Netzwerks ersten Grades von J. Henri Bayle
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Private Company | Biotechnology | 32 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von J. Henri Bayle
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
INCYTE CORPORATION | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal | |
OSIRIS THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer Chief Executive Officer | |
MARKER THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Compliance Officer | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
University of Virginia | College/University | Undergraduate Degree | |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Mercer University | College/University | Doctorate Degree | |
McDermott Will & Emery LLP
McDermott Will & Emery LLP Miscellaneous Commercial ServicesCommercial Services McDermott Will & Emery LLP provides legal services. The company's practices include corporate, employee benefits, health law, intellectual property, private clients, regulation and government affairs, tax, and trial. The company was founded in 1934 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Georgia State University | College/University | Undergraduate Degree | |
Yale University | College/University | Undergraduate Degree Graduate Degree | |
Murray State University (Kentucky) | College/University | Undergraduate Degree | |
Utah State University | College/University | Doctorate Degree Doctorate Degree | |
Weber State University | College/University | Undergraduate Degree | |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Baylor College of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | Biotechnology | Chief Executive Officer President | |
Children's Hospital of Wisconsin, Inc.
Children's Hospital of Wisconsin, Inc. Hospital/Nursing ManagementHealth Services Children's Hospital of Wisconsin, Inc. is a healthcare organization that focuses on the physical, social, and mental well-being of children. The non-profit company is based in Wauwatosa, WI and was founded by William Grossman. The company provides child-friendly environments, resources, and medical knowledge to impact children's health at home and school. Children's Hospital of Wisconsin has been nationally ranked among the best in the nation in four specialties, according to the U.S. News & World Report's 2023-24 Best Children's Hospitals report. The company is committed to doing the best for kids at every turn and are a charitable, tax-exempt organization. | Hospital/Nursing Management | Founder | |
KARA THER | Pharmaceuticals: Major | Director/Board Member | |
Georgetown University Law Center | College/University | Graduate Degree | |
Washington University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
XENETIC BIOSCIENCES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Chief Operating Officer | |
Chandler Medical Center | College/University | Doctorate Degree | |
LANDMARK INFRASTRUCTURE PARTNERS LP | Real Estate Development | Director/Board Member | |
Pacific GeneTech Ltd.
Pacific GeneTech Ltd. BiotechnologyHealth Technology Pacific GeneTech Ltd. is a biotech company based in Hong Kong, Hong Kong. Pacific GeneTech develops and commercializes next-generation vaccines and biologics for areas of high unmet or underserved needs in food safety and animal health. The Chinese company's proprietary "Aegis" vaccine platform combines cross-protective antigens and immunopotentiators in PGT vectors for broad-spectrum protection against multiple strains and species of infectious diseases. PGT has out-licensed its adjuvant for use in third-party vaccines and is developing broad applications for its adjuvant/delivery system. The private company's "Hercules" adjuvant/delivery system provides enhanced efficacy of inactivated and DNA vaccines, and its "Argo" yeast vector is a safe, flexible, and robust carrier of immunogenic material. PGT has out-licensed two of its leading poultry vaccines addressing economically important gastro-intestinal pathogens and has out-licensed its Hercules adjuvant for use in third-party vaccines. Vaccines for other pathogens and animal species are under development, including an experimental DNA vaccine for African swine fever. PGT is developing other applications for its Hercules adjuvant/delivery system and for the Argo vector. The company, through its affiliate company, PGTX, has commenced programs with collaborators addressing human dysentery and related diseases, and malaria. The company was founded in 2009, and the CEO is Tim Collard. | Biotechnology | Director/Board Member | |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Pionyr Immunotherapeutics, Inc.
Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Sidley Austin LLP
Sidley Austin LLP Miscellaneous Commercial ServicesCommercial Services Sidley Austin LLP is a premier legal adviser with over 2000 lawyers in 20 offices worldwide. Sidley Austin is based in Chicago, IL and has subsidiaries in Germany, Hong Kong, United States, United Kingdom, and Japan. The firm has been providing superior client service for over 150 years and has a diverse group of legal professionals from many cultures who are dedicated to teamwork and collaboration. Sidley Austin has forged enduring relationships with the business community and serves a varied and high-caliber group of market leaders, many of whom are pioneers in their respective industries and professions. The firm is committed to pro bono service and its lawyers and staff devote more than 100,000 hours annually to serving those most in need. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Insitro, Inc.
Insitro, Inc. BiotechnologyHealth Technology Insitro, Inc. engages in engages in the discovery and development of drug products. Its approach include population scale data, cell-based disease models, biology at scale, cutting-edge machine learning, and predictive insights and new medicines. The company was founded by Daphne Koller and is headquartered in Portola Valley, CA. | Biotechnology | Director/Board Member | |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Asher Biotherapeutics, Inc. engages in the research and development of immunotherapy for cancer. The company was founded by Ivana Djuretic and Andy Yeung in 2019 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Biotechnology | Founder Human Resources Officer | |
Bryologyx, Inc.
Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Bryologyx, Inc. operates as a biopharmaceutical company focused on treating cancer immunotherapies. The company was founded by Thomas M. Loarie, John H. Abeles, Paul A. Wender and Sam Kongsamut and is headquartered in Danville, CA. | Pharmaceuticals: Major | Director/Board Member | |
MOMA Therapeutics, Inc.
MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Human Resources Officer | |
TANGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Vereinigte Staaten | 50 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 31 |
Consumer Services | 12 |
Commercial Services | 6 |
Finance | 4 |
Health Services | 2 |
Operativ
Director/Board Member | 75 |
Corporate Officer/Principal | 73 |
Undergraduate Degree | 31 |
Independent Dir/Board Member | 27 |
Chief Tech/Sci/R&D Officer | 23 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
James Farrell Brown | 20 |
Kevin M. Slawin | 20 |
Reid Huber | 16 |
Alan Musso | 15 |
William Grossman | 13 |
James Daly | 13 |
Annemarie B. Moseley | 12 |
Peter Hoang | 12 |
Alan K. Smith | 12 |
Stephen Davis | 11 |
Shane Ward | 10 |
Jon Stonehouse | 10 |
Edmund Harrigan | 10 |
Gregory S. Naeve | 9 |
Atabak Mokari | 9 |
- Börse
- Insiders
- J. Henri Bayle
- Unternehmensverbindungen